Bleeding in the gut for heart patients on antiplatelets
Part of Digestive system, Heart & circulation clinical trials.
This study looks at patients with heart disease who take antiplatelet drugs (like aspirin or clopidogrel) and then develop bleeding in the stomach or intestines. The goal is to understand and improve care for this bleeding while managing heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with ischemic heart disease (blocked arteries in the heart).
- You are taking one or two antiplatelet medicines (like aspirin or clopidogrel) to prevent heart attacks.
- You have had signs of bleeding in your digestive tract, such as vomiting blood, black stools, or blood in your rectum.
- You are not taking anticoagulant blood thinners (like warfarin) and do not have other serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether omeprazole (a stomach acid reducer) can help prevent stomach bleeding in older adults who are taking blood thinners for a newly diagnosed blood clot. It may be a good fit if you are 65 or older and starting blood thinners for a clot.
This study collects information from patients who come to the emergency room with gastrointestinal bleeding while taking certain newer blood thinners. It aims to better understand and manage this type of bleeding.
This study looks at patients who develop bleeding in the stomach or intestines while in the intensive care unit (ICU). It aims to understand how common this is and what factors might be involved, which could help improve care for future patients.
This study looks at blood-related problems in people who have bleeding from abnormal blood vessels in the digestive tract (angiodysplasia). It aims to better understand these blood issues and may help improve future care.
This trial compares a potassium-competitive acid blocker to a proton pump inhibitor to help prevent stomach or intestinal bleeding in people at high risk who take blood-thinning medicines. It may help reduce dangerous GI bleeding while you stay on heart/stroke medicines.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
Hear when a new Antiplatelet Drugs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.